Interventricular dispersion in repolarization causes bifid T waves in dogs with dofetilide-induced long QT syndrome

Heart Rhythm. 2015 Jun;12(6):1343-51. doi: 10.1016/j.hrthm.2015.02.026. Epub 2015 Feb 24.

Abstract

Background: Long QT2 (LQT2) syndrome is characterized by bifid (or notched) T waves, whose mechanism is not understood.

Objective: The purpose of this study was to test whether increased interventricular dispersion of repolarization induces bifid T waves.

Methods: We simultaneously recorded surface ECG and unipolar electrograms at baseline and after dofetilide in a canine model of dofetilide-induced LQT2 (6 male mongrel dogs). Standard ECG variables, T-wave duration, and moments of peaks of bifid T waves (Tp1 and Tp2) were correlated with moments of local repolarization. Epicardial electrograms were recorded over the left ventricular (LV) and right ventricular (RV) anterior walls (11 × 11 electrode grid, 5-mm interelectrode distance). In 5 of the 6 hearts, we also recorded intramural unipolar electrograms (n = 4-7 needles per heart). In each unipolar recording, we determined activation time, repolarization time (RTs), and activation-recovery interval. In addition, we studied RT response to heart rate changes.

Results: Dofetilide prolonged QT and QTc, induced bifid T waves in 4 of 6 animals, and prolonged RT heterogeneously in LV and RV, resulting in increased interventricular and LV intraventricular RT dispersion. Dofetilide did not induce a disparate response in activation-recovery interval across the transmural axis. Dofetilide-induced separation of RT across the RV-LV interface concurred with the moments of T-wave peaks. Dofetilide-induced steepening of restitution slopes was larger in LV than RV.

Conclusion: Dofetilide-induced bifid T waves result from interventricular RT dispersion.

Keywords: Bifid T wave; Dog; Long QT syndrome type 2; Repolarization.

MeSH terms

  • Animals
  • Dogs
  • Electrocardiography*
  • Long QT Syndrome / chemically induced*
  • Long QT Syndrome / physiopathology*
  • Male
  • Phenethylamines*
  • Potassium Channel Blockers*
  • Sulfonamides*

Substances

  • Phenethylamines
  • Potassium Channel Blockers
  • Sulfonamides
  • dofetilide